WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. ("AGI" or the "Company") (TSX: AFN) today announced that Tim Close has stepped down as President and Chief Executive Officer and resigned as a Director of AGI to pursue other opportunities.
BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery platform today announ
VANCOUVER, British Columbia--(BUSINESS WIRE)--Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovati
SASKATOON, Saskatchewan--(BUSINESS WIRE)--#agribusiness--Modern society would not be possible without biotechnology. From vaccines and medicines, to crops, foods, cleaners, and industrial products, biotechnology benefits every area of our lives. In Saska
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI” or the “Company”) today announced the declaration of a cash dividend of $0.15 per common share for the third quarter ending September 30, 2022. The dividend is pay
Eat Well Group is forecasting combined company profitability in 2022, with positive Adjusted EBITDA of $4.0-5.0 million for Calendar Year 2022 VANCOUVER, British Columbia--(BUSINESS WIRE)--Eat Well Investment Group Inc. (the “Company” or “Eat Well
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the results from
WINNIPEG, Manitoba--(BUSINESS WIRE)--$FDGE #AgTech--Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE), a pure-play digital agriculture company, today announced the resignation of Wade Barnes as a member of the Board of Directors. Ab
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM, is pleased to announce its participation in the following upcoming
Our partner BioTalent Canada has launched the Building Workplace Resiliency resources for its I.D.E.A.L. Biosciences Employer Recognition Program. This program served as a guide for employers seeking to submit fall program applications.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.